Kiniksa Pharmaceuticals International, plc (KNSA) Return on equity 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
10.4%FY2025 · since FY2021: -85.3% → 10.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.4% | +20.2 pp |
| FY2024 | -9.9% | -13.1 pp |
| FY2023 | 3.2% | -43.1 pp |
| FY2022 | 46.3% | +131.6 pp |
| FY2021 | -85.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice